Yazılar

NICE to Recommend Eli Lilly’s Obesity Drug Mounjaro for NHS Use

/in /tarafından

The UK’s National Institute for Health and Care Excellence (NICE) announced on Thursday that it plans to recommend Eli Lilly’s obesity drug Mounjaro for use through the National Health Service (NHS), potentially benefiting 220,000 patients over the next three years.

Previously available in the UK only through private, out-of-pocket purchases, Mounjaro, launched in February 2023, will now be prescribed alongside lifestyle changes like diet and exercise. The eligibility criteria include individuals with a body mass index (BMI) over 35 and at least one weight-related condition such as heart disease or type 2 diabetes.

Phased Rollout and Eligibility

Approximately 3.4 million people in England could qualify for the treatment under the stated guidelines. However, during the initial rollout, priority will be given to those with the highest clinical need. The drug will become accessible to NHS patients starting 90 days after NICE’s final guidance is published, scheduled for December 23, unless appeals are lodged. Patients who are part of specialist NHS weight management services will gain earlier access, while others may need to wait up to 180 days.

The phased rollout is essential to ensure that healthcare providers can continue addressing the broader range of patient needs, NICE stated.

Mounjaro’s Potential Impact

Mounjaro, part of the GLP-1 analogue drug class, was initially developed to manage blood sugar levels in type 2 diabetes patients but has shown remarkable efficacy in promoting weight loss. Clinical trials demonstrated an average weight loss of nearly 23%, making it one of the most effective options for obesity management.

This recommendation aligns with earlier guidelines issued by NICE for Novo Nordisk’s Wegovy in March 2023, which targets the same BMI threshold and weight-related conditions.

Addressing Britain’s Obesity Crisis

With nearly one in three adults in Britain classified as obese—the highest rate in Europe according to a 2019 OECD report—Mounjaro offers a new tool to address the nation’s obesity epidemic. The European Union’s obesity average stands at 16.5%, highlighting the urgent need for interventions in the UK.

Eli Lilly has welcomed NICE’s decision and acknowledged the necessity of a phased introduction, ensuring the drug is integrated effectively into the NHS system.

Swapped at Birth: Two Women Discover Their True Identities

/in /tarafından

In a startling revelation, two families in the West Midlands are awaiting compensation following the first documented case of babies being switched at birth in NHS history. This unexpected twist of fate began with a simple DNA test that forced two women and their families to reconsider their entire identities.

Tony received a DNA home-testing kit as a Christmas gift in 2021 but left it unopened for two months. Finally, during a rainy February day, he decided to test the kit out. After sending in his sample, he didn’t give it much thought until he received the results one Sunday evening while on the phone with his mother, Joan.

Initially, the results aligned with his expectations, revealing information about his maternal lineage. However, the name listed as his sister was not Jessica, as he had always known her, but Claire. This unexpected finding triggered concerns for both Tony and his mother, who was in her 80s and living alone after her husband’s death.

An Unexpected Connection

Eager for answers, Tony contacted Claire through the DNA testing service’s messaging feature. Claire had also taken the same DNA test two years prior, prompted by her son. Her results had also raised questions about her familial connections, revealing a genetic link to a first cousin she did not recognize.

As Claire and Tony began exchanging details, they discovered that Claire was born around the same time and in the same hospital as Jessica. It soon became clear that they had been swapped at birth, a shocking realization given the rarity of such occurrences in the UK. According to a 2017 Freedom of Information request, the NHS had no documented cases of babies being sent home with the wrong parents prior to this incident.

The absence of such cases is largely attributed to protocols established in the 1980s, where newborns receive radio frequency identification (RFID) tags for tracking.

Embracing the Truth

Confronted with this life-altering news, Tony and Claire discussed their next steps. “The ripples from this will be enormous,” Tony acknowledged. Claire, however, expressed an eagerness to meet Tony and their biological mother.

When Tony finally shared the discovery with Joan, she was desperate for clarity about how such a mix-up could occur. Her memories of the day Claire was born remained vivid; she had been induced at a West Midlands hospital due to high blood pressure and had briefly held her long-awaited daughter before she was taken to the nursery for the night. The following day, she was handed Jessica, who had fair hair unlike the rest of the family, but Joan attributed this to distant relatives.

After 55 years, Joan longed to know more about Claire’s life. Before they could reach out to her, Tony and Joan had to inform Jessica about the revelation. Their relationship has since changed, as Jessica has not agreed to be interviewed regarding the situation.

A Moment of Connection

Only five days after the initial DNA results, Claire visited Joan. For years, she had unknowingly passed through the village where her biological mother lived. Upon arrival, Tony welcomed her with a warm, “Hi Sis,” and invited her to meet Joan.

Instantly, Claire felt a profound connection to Joan, exclaiming, “Oh my God, I’ve got your eyes! We have the same eyes. Oh my God, I look like someone!” Joan echoed this sentiment, remarking how Claire resembled her in her younger days. They spent time sharing family photos and stories, but when it came to Claire’s childhood, she chose to withhold the truth, revealing only that her upbringing had been challenging.

Claire faced practical challenges too, realizing that her birth certificate and identification documents were inaccurate due to the mix-up.

Seeking Accountability

Weeks after their discovery, Tony reached out to the NHS trust overseeing the hospital involved, explaining the DNA test findings. The trust accepted liability for what it termed an “appalling error,” but discussions regarding compensation have yet to be finalized, even two and a half years later.

Despite the turmoil, Claire and Joan have found common ground, bonding over shared interests and experiences. They have traveled together to explore their Irish roots and spent holidays side by side.

“I’d like to spend as much time as I can with them, of course, but that time is gone. It was taken away,” Claire reflected. While Claire now refers to Joan as “Mum,” Jessica’s relationship with Joan remains strained. Yet Joan emphasizes that her love for Jessica remains unchanged. “It doesn’t make any difference to me that Jessica isn’t my biological daughter. She’s still my daughter, and she always will be,” Joan affirmed.